Home
Careers
Contact
About Us
News
Investors | Partners
Products | Research
Highlights
Noah Rosenberg, MD, Joins Esperion Therapeutics as Chief Medical Officer
April 8, 2012
Esperion announces positive phase 2 clinical trial results for ETC-1002
March 25, 2012
Esperion announces results from Phase 1 study and four preclinical studies for ETC-1002
May 2, 2011